October 24, 2019
Healthcare AI company Viz.ai announced that it landed a whopping $50 million in Series B funding this morning. This latest infusion of cash was led by Greenoaks, with participation from Threshold Ventures, CRV, GV and Kleiner Perkins.
The new funding comes a little over a year after the Israeli company raised $21 million from Kleiner Perkins and GV.
WHAT THEY DO
Viz.ai focuses on using AI to...
July 25, 2019
Healthcare artificial intelligence company Viz.ai announced that it is joining forces with Medtronic with the goal of speeding up adoption of the former’s technology. Specifically the pair will be working on getting Viz.ai’s system, which specializes on stroke detection, into more stroke treatment centers in the US.
“Medtronic is an innovative company focused on therapies that extend life and...
November 15, 2018
Every day sees strides across the field of artificial intelligence, and healthcare is just one of the many industries looking to smart automation as a means to reduce burden and improve results. The last year in particular has brought a wealth of new healthcare focused software tools to the forefront, and as such has ignited debate on how these algorithms are being reviewed and regulated by the...
July 26, 2018
WebMD goes to China. WebMD is teaming up with Chinese tech giant Tencent in a deal that would introduce the health information platform to Asia. This means that WebMD’s services will be translated into Chinese and localized to suit the Chinese population.
“The agreement between WebMD and Tencent has the power to make a difference in the health of the Chinese people,” said Meng Zhang, general...
July 18, 2018
Healthcare AI company Viz.ai announced today that it has raised $21 million in Series A funding. The investment was led by Kleiner Perkins, with additional participation from GV (formerly Google Ventures).
Viz.ai’s primary product is Contact, the first FDA-cleared clinical decision support (CDS) tool that analyzes CT results and highlights cases that may have experienced a stroke for review by a...
April 6, 2018
In the last quarter the FDA gave the nod to 10 digital health devices. Innovations that aimed to help diabetes management were popular, ranging from the first integrated continuous glucose monitor, which was put out by Dexcom, to Glooko’s insulin titration tool.
Not all FDA news this quarter was good news. In February Roche’s Accu-Check Connect Diabetes Management App was recalled by the FDA for...
February 14, 2018
The FDA announced yesterday that it will permit marketing of Viz.ai’s Contact, a clinical decision support (CDS) tool that analyzes CT results and highlights cases that may have experienced a stroke.
The CDS application was submitted through the agency’s de novo premarket review pathway, and as such creates a new regulatory classification for similar AI-drived platforms to come. The FDA’s...